$OFIX
Orthofix Medical Inc. Stock $ofix

$ofix Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000156459021054754 Filed on November 05, 2021

Income Statement

Concept	2021 Q3	2020 Q3	2020 Q2
Revenue	$112.4M	$111.0M	$73.14M
YoY Change	1.3%	-2.21%	-36.87%
Cost Of Revenue	$28.31M	$26.20M	$23.20M
YoY Change	8.04%	5.24%	-10.12%
Gross Profit	$84.12M	$84.70M	$50.00M
YoY Change	-0.68%	-4.41%	-44.47%
Gross Profit Margin	74.82%	76.32%	68.37%
Selling, General & Admin	$72.41M	$69.50M	$58.50M
YoY Change	4.19%	-8.43%	-25.76%
% of Gross Profit	86.08%	82.05%	117.0%
Research & Development	$12.36M	$10.00M	$8.800M
YoY Change	23.6%	25.28%	-2.22%
% of Gross Profit	14.69%	11.81%	17.6%
Depreciation & Amortization	$7.151M	$9.000M	$7.000M
YoY Change	-20.54%	42.86%	12.9%
% of Gross Profit	8.5%	10.63%	14.0%
Operating Expenses	$84.43M	$80.60M	$70.90M
YoY Change	4.76%	-25.01%	-20.86%
Operating Profit	-$313.0K	$4.100M	-$20.90M
YoY Change	-107.63%	-121.71%	-4734.15%
Interest Expense	-$433.0K	-$700.0K	-$900.0K
YoY Change	-38.14%	-450.0%	-280.0%
% of Operating Profit		-17.07%
Other Income/Expense, Net	-$1.789M	$1.800M	$5.100M
YoY Change	-199.39%	-122.1%	-2650.0%
Pretax Income	-$2.535M	$5.261M	-$16.83M
YoY Change	-148.18%	-119.6%	-2604.76%
Income Tax	-$364.0K	$600.0K	$1.600M
% Of Pretax Income		11.4%
Net Earnings	-$2.171M	$4.654M	-$18.42M
YoY Change	-146.65%	-111.49%	3268.19%
Net Earnings / Revenue	-1.93%	4.19%	-25.19%
Basic Earnings Per Share	$0.11
Diluted Earnings Per Share	-$109.8K	$242.3K	-$958.3K
COMMON SHARES
Basic Shares Outstanding	19.77K	19.34M	19.22M
Diluted Shares Outstanding	19.77M	19.40M	19.22M

Balance Sheet

Concept	2021 Q3	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.71M	$79.80M	$172.9M
YoY Change	3.65%	40.49%	231.86%
Cash & Equivalents	$82.71M	$79.81M	$172.9M
Short-Term Investments
Other Short-Term Assets	$23.85M	$19.00M	$21.20M
YoY Change	25.54%	-6.4%	0.95%
Inventory	$84.68M	$82.86M	$82.05M
Prepaid Expenses
Receivables	$68.97M	$73.10M	$67.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$260.2M	$254.7M	$343.6M
YoY Change	2.16%	7.11%	47.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$62.36M	$68.70M	$70.30M
YoY Change	-9.24%	9.11%	9.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$37.98M	$45.70M	$38.70M
YoY Change	-16.9%	338.58%	42.26%
Total Long-Term Assets	$240.2M	$262.4M	$252.1M
YoY Change	-8.47%	10.34%	-1.51%
TOTAL ASSETS
Total Short-Term Assets	$260.2M	$254.7M	$343.6M
Total Long-Term Assets	$240.2M	$262.4M	$252.1M
Total Assets	$500.4M	$517.1M	$595.7M
YoY Change	-3.23%	8.73%	21.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.44M	$16.90M	$14.90M
YoY Change	15.01%	-5.54%	-23.68%
Accrued Expenses	$2.002M	$2.000M	$1.900M
YoY Change	0.1%	11.11%	5.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.570M	$500.0K	$400.0K
YoY Change	414.0%	66.67%	33.33%
Total Short-Term Liabilities	$80.00M	$93.40M	$89.60M
YoY Change	-14.34%	5.53%	31.79%
LONG-TERM LIABILITIES
Long-Term Debt	$20.04M	$22.50M	$100.0M
YoY Change	-10.92%	8.17%	380.77%
Other Long-Term Liabilities	$35.51M	$46.39M	$38.60M
YoY Change	-23.45%	-22.54%	-26.03%
Total Long-Term Liabilities	$55.56M	$46.39M	$100.0M
YoY Change	19.75%	-22.54%	91.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.00M	$93.40M	$89.60M
Total Long-Term Liabilities	$55.56M	$46.39M	$100.0M
Total Liabilities	$135.6M	$162.2M	$250.7M
YoY Change	-16.44%	-4.1%	77.79%
SHAREHOLDERS EQUITY
Retained Earnings		$68.76M
YoY Change		49.27%
Common Stock		$287.1M
YoY Change		8.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$364.8M	$354.9M	$345.0M
YoY Change
Total Liabilities & Shareholders Equity	$500.4M	$517.1M	$595.7M
YoY Change	-3.24%	8.73%	21.87%

Cashflow Statement

Concept	2021 Q3	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	-$2.171M	$4.654M	-$18.42M
YoY Change	-146.65%	-111.49%	3268.19%
Depreciation, Depletion And Amortization	$7.151M	$9.000M	$7.000M
YoY Change	-20.54%	42.86%	12.9%
Cash From Operating Activities	$6.432M	$21.90M	$17.60M
YoY Change	-70.63%	85.59%	89.25%
INVESTING ACTIVITIES
Capital Expenditures	-$4.239M	-$9.300M	-$4.400M
YoY Change	-54.42%	102.17%	-18.52%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$5.000M	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$4.239M	-$14.30M	-$4.400M
YoY Change	-70.36%	210.87%	-18.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	855.0K	-101.3M	101.6M
YoY Change	-100.84%	10030.0%	-8566.67%
NET CHANGE
Cash From Operating Activities	6.432M	21.90M	17.60M
Cash From Investing Activities	-4.239M	-14.30M	-4.400M
Cash From Financing Activities	855.0K	-101.3M	101.6M
Net Change In Cash	3.048M	-93.70M	114.8M
YoY Change	-103.25%	-1611.29%	4151.85%
FREE CASH FLOW
Cash From Operating Activities	$6.432M	$21.90M	$17.60M
Capital Expenditures	-$4.239M	-$9.300M	-$4.400M
Free Cash Flow	$10.67M	$31.20M	$22.00M
YoY Change	-65.8%	90.24%	49.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q3	ofix	Operating Lease Rights Of Use Assets Statement Of Financial Position Extensible List OperatingLeaseRightsOfUseAssetsStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q4	ofix	Operating Lease Rights Of Use Assets Statement Of Financial Position Extensible List OperatingLeaseRightsOfUseAssetsStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2021Q3	ofix	Finance Lease Rights Of Use Assets Statement Of Financial Position Extensible List FinanceLeaseRightsOfUseAssetsStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentNet
CY2020Q4	ofix	Finance Lease Rights Of Use Assets Statement Of Financial Position Extensible List FinanceLeaseRightsOfUseAssetsStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentNet
CY2021Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2171000
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-334000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3842000
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1212000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	364833000
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-719000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	25665000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1711000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3859000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	812000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	355369000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-18424000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110985000
	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13851000
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	6595000
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	68000
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	17455000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6696000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51981000
	us-gaap	Share Based Compensation ShareBasedCompensation	11470000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1484000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4699000
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1917000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	345045000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4654000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2275000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3841000
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-919000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	354896000
	us-gaap	Net Income Loss NetIncomeLoss	-5567000
	us-gaap	Net Income Loss NetIncomeLoss	11895000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22153000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22299000
	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	2645000
	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	2811000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	376000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	945000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2228000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2471000
	us-gaap	Share Based Compensation ShareBasedCompensation	12399000
	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	305000
	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	-219000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2375000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7600000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-743000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1798000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2729000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11551000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	866000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-246000
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	6987000
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-2453000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2983000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3106000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3951000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5742000
	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	-5951000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11560000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11625000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	18000000
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	100000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6238000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3839000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2184000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2029000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	395000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	277000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13606000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9897000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	96821000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	70403000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	83215000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	204000
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	8405000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-927000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1023000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5673000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	583000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-598000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1221000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1079000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5000000
	ofix	Asset Acquisitions And Other Investments AssetAcquisitionsAndOtherInvestments	1250000
	ofix	Asset Acquisitions And Other Investments AssetAcquisitionsAndOtherInvestments	7240000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14031000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42944000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80300000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82710000
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79810000
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	505000
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	490000
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1575000
CY2021Q3	ofix	Cares Act2020 Impact On Income Tax Expense Benefit CARESAct2020ImpactOnIncomeTaxExpenseBenefit	0
	ofix	Cares Act2020 Impact On Income Tax Expense Benefit CARESAct2020ImpactOnIncomeTaxExpenseBenefit	0
CY2020Q2	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13900000
CY2020Q4	ofix	Cares Act Of2020 Deferred Taxes Payments CARESActOf2020DeferredTaxesPayments	600000
CY2021Q3	us-gaap	Deferred Long Term Liability Charges DeferredLongTermLiabilityCharges	0
CY2021Q3	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	22685000
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	7992000
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8442000
CY2021Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14977000
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12149000
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17164000
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	29142000
CY2021Q3	ofix	Inventory Field And Consignment Net Of Reserves InventoryFieldAndConsignmentNetOfReserves	44545000
CY2020Q4	ofix	Inventory Field And Consignment Net Of Reserves InventoryFieldAndConsignmentNetOfReserves	34902000
CY2021Q3	us-gaap	Inventory Net InventoryNet	84678000
CY2020Q4	us-gaap	Inventory Net InventoryNet	84635000
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3571000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4840000
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	19114000
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	20552000
CY2020Q4	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	25392000
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2002000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2092000
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2570000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	510000
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1713000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2946000
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20044000
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	22338000
CY2021Q3	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	26329000
CY2020Q4	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	27886000
	us-gaap	Operating Lease Payments OperatingLeasePayments	3469000
	us-gaap	Operating Lease Payments OperatingLeasePayments	3170000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	680000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	458000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	395000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	204000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	460000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	619000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	149000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1949000
CY2021Q3	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	600000
	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	1100000
CY2020Q3	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	400000
	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	1100000
CY2021Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	7700000
CY2021Q3	ofix	Freezing Amount In Cash Resulted From Court Pending Legal Action Issued FreezingAmountInCashResultedFromCourtPendingLegalActionIssued	500000
CY2021Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	800000
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112428000
CY2021Q3	ofix	Percentage Of Reported Increase Decrease PercentageOfReportedIncreaseDecrease	0.013
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288943000
	ofix	Percentage Of Reported Increase Decrease PercentageOfReportedIncreaseDecrease	0.175
CY2020Q3	ofix	Revenue From Product Sales RevenueFromProductSales	96305000
	ofix	Revenue From Product Sales RevenueFromProductSales	299214000
	ofix	Revenue From Product Sales RevenueFromProductSales	250161000
CY2021Q3	ofix	Marketing Service Fees MarketingServiceFees	12424000
CY2020Q3	ofix	Marketing Service Fees MarketingServiceFees	14680000
	ofix	Marketing Service Fees MarketingServiceFees	40201000
	ofix	Marketing Service Fees MarketingServiceFees	38782000
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112428000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110985000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	339415000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4471000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6364000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4848000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3987000
	ofix	Impact Of Adoption Of Asu201613 ImpactOfAdoptionOfASU201613	1120000
CY2021Q3	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	-590000
CY2020Q3	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	619000
	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	-376000
	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	-945000
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	54000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	309000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	134000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	647000
CY2021Q3	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	79000
CY2020Q3	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	-88000
	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	162000
	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	-119000
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4928000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5524000
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4928000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5524000
CY2020Q2	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13900000
CY2021Q4	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	11 months
CY2022Q3	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	6 months
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7900000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10971000
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	13851000
CY2021Q3	ofix	Recoupment Recognized In Net Sales RecoupmentRecognizedInNetSales	-3071000
	ofix	Recoupment Recognized In Net Sales RecoupmentRecognizedInNetSales	-5951000
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7900000
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7900000
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021Q3	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	5049000
CY2020Q3	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	15022000
	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	19663000
	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	18416000
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7151000
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9030000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22153000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22299000
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-433000
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-731000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1400000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2055000
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2535000
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5261000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3890000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5938000
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112428000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110985000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	339415000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288943000
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2300000
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-700000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2375000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7600000
CY2021Q3	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	1965000
CY2020Q3	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	1838000
	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	5903000
	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	4834000
	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	1500000
CY2021Q3	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-335000
CY2020Q3	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	1138000
	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	5028000
	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-2766000
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3842000
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3841000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11470000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12399000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12399000
	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	244801
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	3.003
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19769823
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19398567

Files In Submission

Name	View Source	Status
0001564590-21-054754-index-headers.html	Edgar Link	pending
0001564590-21-054754-index.html	Edgar Link	pending
0001564590-21-054754.txt	Edgar Link	pending
0001564590-21-054754-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grozbbb43aiq000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ofix-10q_20210930.htm	Edgar Link	pending
ofix-10q_20210930_htm.xml	Edgar Link	completed
ofix-20210930.xsd	Edgar Link	pending
ofix-20210930_cal.xml	Edgar Link	unprocessable
ofix-20210930_def.xml	Edgar Link	unprocessable
ofix-20210930_lab.xml	Edgar Link	unprocessable
ofix-20210930_pre.xml	Edgar Link	unprocessable
ofix-ex311_8.htm	Edgar Link	pending
ofix-ex312_6.htm	Edgar Link	pending
ofix-ex321_7.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OFIX
Orthofix Medical Inc. Stock $ofix

2021 Q3 Form 10-Q Financial Statement

#000156459021054754 Filed on November 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX Orthofix Medical Inc. Stock $ofix

2021 Q3 Form 10-Q Financial Statement

#000156459021054754 Filed on November 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX
Orthofix Medical Inc. Stock $ofix